4D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab)
4d Pharma PLC (AIM:DDDD) Update on Administration and Suspension of Trading
Leeds, UK – December 30, 2022 – 4D pharma plc (AIM: DDDD) (in administration), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived
OKYO Pharma LTD (AIM:OKYO) Interim Results for the Six Months Ending 30 September 2022
OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO),— an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat Dry Eye Disease (DED) to address the significant unmet need in this multi-billion-dollar market, today
Apple and Tesla: Shares tumble amid supply issues
Tesla and Apple stock prices have plummeted due to growing concerns over delays in China’s production lines.
Argo Blockchain PLC (LON:ARB) Transformational Strategic Transaction with Galaxy
Announcement of Transformational Strategic Transactions with Galaxy Digital Holdings, Ltd.
OKYO Pharma Limited (AIM:OKYO) U.S. FDA Clearance of IND Application for OK-101
OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease
OKYO Pharma Limited (AIM:OKYO) OKYO to Participate at Biotech Showcase
London and New York, NY., 21 December, 2022 – OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to
Argo Blockchain PLC (LON:ARB) Restoration of Trading on the London Stock Exchange
Argo Blockchain plc, a global leader in cryptocurrency mining (LSE: ARB; Nasdaq: ARBK), makes the following announcement:
Argo Blockchain PLC (LON:ARB) The Financial Conduct Authority temporarily suspends the securities
NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST Argo Blockchain PLC
4d Pharma PLC (AIM:DDDD) Blautix Phase II Clinical Trial Results Published
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics
4d Pharma PLC (AIM:DDDD) MRx0518 poster presentations at SITC 2022
4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)